Yihe Daida to United States
This is a "connection" page, showing publications Yihe Daida has written about United States.
Connection Strength
0.392
-
Mental and physical health status among chronic hepatitis B patients. Qual Life Res. 2020 Jun; 29(6):1567-1577.
Score: 0.095
-
Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide. JAMA Psychiatry. 2024 Jul 01; 81(7):717-726.
Score: 0.032
-
Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine. J Clin Psychiatry. 2024 Apr 29; 85(2).
Score: 0.032
-
Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity. Br J Cancer. 2024 May; 130(8):1286-1294.
Score: 0.032
-
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co-infection and risk of drug-induced liver injury across two large HBV cohorts in the United States. J Viral Hepat. 2023 06; 30(6):512-519.
Score: 0.030
-
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017. J Clin Gastroenterol. 2021 01; 55(1):77-83.
Score: 0.025
-
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure. Hepatol Commun. 2021 03; 5(3):400-411.
Score: 0.025
-
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clin Infect Dis. 2019 03 05; 68(6):956-963.
Score: 0.022
-
Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C. Liver Int. 2019 06; 39(6):1027-1032.
Score: 0.022
-
Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United States. J Viral Hepat. 2018 08; 25(8):952-958.
Score: 0.021
-
Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States. Gastroenterology. 2018 02; 154(3):754-758.
Score: 0.021
-
Changing trends in complications of chronic hepatitis C. Liver Int. 2018 02; 38(2):239-247.
Score: 0.020
-
KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
Score: 0.014